Axcelis Technologies and Veeco Instruments to Combine in All-Stock Merger

Vectrus and The Vertex Company to Combine in All-Stock Merger

March 7, 2022

Aerospace & Defense

Vectrus, Inc. and The Vertex Company announced an all-stock merger to create a leading global provider of mission-essential government services. The combined company will have pro forma 2021 revenue of approximately $3.4 billion, pro forma backlog of about $11.3 billion, and is expected to deliver cost synergies and enhanced capabilities while maintaining Vectrus’s NYSE listing and a Northern Virginia headquarters post-close.

II‑VI Incorporated Acquires Coherent, Inc.

July 1, 2022

Manufacturing

II‑VI Incorporated completed the acquisition of Coherent, Inc., combining II‑VI’s engineered materials and components business with Coherent’s laser and photonics capabilities. Under the merger agreement each Coherent share was converted into $220.00 in cash and 0.91 of a share of II‑VI common stock, creating a combined company with a global workforce of more than 28,000 and expanded scale across materials, networking and lasers.

Gentex Acquires VOXX International in $196M All-Cash Merger

April 1, 2025

Manufacturing

Gentex Corporation agreed to acquire VOXX International Corporation in an all-cash transaction valued at approximately $196 million, at $7.50 per share. The deal closed on April 1, 2025 after stockholder approval and satisfaction of closing conditions.

Excelitas Technologies Acquires Phoseon Technology

February 15, 2023

Manufacturing

Excelitas Technologies Corp. completed the acquisition of Phoseon Technology, Inc. on February 15, 2023, adding Phoseon's LED-based UV curing and scientific illumination capabilities to its commercial business unit. Phoseon will continue to operate from its Hillsboro, Oregon headquarters and the deal expands Excelitas' product portfolio and R&D cooperation in UV LED solutions across industrial, medical device, electronics and life-sciences end markets.

MEI Pharma and Infinity Pharmaceuticals Announce Definitive All-Stock Merger

February 24, 2023

Pharmaceuticals

MEI Pharma, Inc. and Infinity Pharmaceuticals, Inc. entered into a definitive merger agreement for an all-stock transaction to form a combined clinical-stage oncology company. The merged organization will advance a pipeline of three clinical-stage oncology drug candidates, including eganelisib, voruciclib, and ME-344.

Voyager Acquisition Corp and VERAXA Biotech Announce Form F-4 Filing for Proposed Business Combination

July 17, 2025

Healthcare Services

VERAXA Biotech AG and Voyager Acquisition Corp. (a SPAC) have filed a Form F-4 registration statement with the SEC in connection with their proposed business combination announced in April 2025. Under the terms, VERAXA shareholders are expected to roll over 100% of their equity and receive approximately 130 million ordinary shares of the combined company, with the deal expected to close in Q4 2025.